VP

venBio Partners Portfolio holdings

AUM $115M
1-Year Est. Return 33.99%
This Quarter Est. Return
1 Year Est. Return
-33.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$115M
AUM Growth
-$8.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

1
+$5.5M
2
+$1.05M

Top Sells

1
+$9.4M
2
+$75.5K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PHVS icon
1
Pharvaris
PHVS
$1.35B
$75.5M 65.78%
4,289,304
HRMY icon
2
Harmony Biosciences
HRMY
$1.54B
$15.5M 13.47%
489,194
ALMS
3
Alumis Inc
ALMS
$482M
$13.9M 12.08%
4,619,803
+1,832,405
LYEL icon
4
Lyell Immunopharma
LYEL
$324M
$4.19M 3.65%
473,479
+118,369
ALXO icon
5
ALX Oncology
ALXO
$91M
$4.03M 3.51%
9,699,925
ARTV
6
Artiva Biotherapeutics
ARTV
$70.1M
$1.73M 1.51%
1,148,975
-50,000
SLRN
7
DELISTED
ACELYRIN
SLRN
– –
-3,806,410